NCT05399862View on ClinicalTrials.gov

The Effect of Lactobacillus Reuteri Probiotic as an Adjunct Treatment for Helicobacter Pylori Infection in Adults

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 24, 2020

Primary Completion Date

December 23, 2021

Study Completion Date

January 10, 2022

Conditions
Helicobacter Pylori Infection
Interventions
DIETARY_SUPPLEMENT

Lactobacillus reuteri DSM 17648 probiotic

Lactobacillus reuteri DSM 17648 is a single-strain probiotic used as adjunct treatment in H.pylori infection

OTHER

Placebo

Placebo capsule with no microbial cell preparation

Trial Locations (1)

56000

The University of Malaysia Medical Centre, Cheras

All Listed Sponsors
collaborator

Y.S.P. Industries (M) Sdn. Bhd, Menara LGB, Taman Tun Dr Ismail, 60000 Kuala Lumpur, Malaysia

UNKNOWN

lead

Universiti Kebangsaan Malaysia Medical Centre

OTHER

NCT05399862 - The Effect of Lactobacillus Reuteri Probiotic as an Adjunct Treatment for Helicobacter Pylori Infection in Adults | Biotech Hunter | Biotech Hunter